Brain electrical activity changes in treatment refractory schizophrenics after olanzapine treatment

被引:5
|
作者
Cerdán, LF
Guevara, MA
Sanz, A
Amezcua, C
Ramos-Loyo, J
机构
[1] Inst Mexicano Seguro Social, Ctr Comunitario Salud Mental 1, Mexico City, DF, Mexico
[2] Univ Guadalajara, Inst Neurociencias, Guadalajara, Jalisco, Mexico
关键词
atypical neuroleptics; coherent activity; EEG; olanzapine; treatment refractory schizophrenia;
D O I
10.1016/j.ijpsycho.2004.12.008
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The aim of the present study was to identify brain electrical activity changes generated by olanzapine (OLZ) in treatment refractory schizophrenics (TRS). 14 paranoid TRS (31.5 +/- 8.39 years old) were evaluated before and after 8 weeks of OLZ treatment. Psychopathology was evaluated by means of total BPRS and PANSS scores. Resting EEG was recorded in the pre (under typical neuroleptics) and post (under OLZ) sessions. A good response to OLZ was observed in 57% of TRS. A significant reduction in positive and negative symptoms scales of PANSS was found. Absolute power of theta1, theta2, alpha1 bands increased after treatment, while beta2 power showed a decrease. Intrahemispheric correlation increased between different zones of the frontal areas and between frontal and posterior areas, while interhemispheric correlation decreased in theta2. EEG changes were more evident in those patients who had a better response to OLZ. OLZ showed to be effective in TRS, improving psychiatric symptoms and increasing activity synchronization between different areas within each hemisphere that may indicate a functional reorganization, particularly in good responders. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:237 / 247
页数:11
相关论文
共 50 条
  • [31] Improvement of tardive dyskinesia after treatment with olanzapine
    Truöl, S
    von Hippel, C
    Raape, J
    König, F
    [J]. PSYCHIATRISCHE PRAXIS, 2002, 29 (06) : 315 - 317
  • [32] USE OF THIORIDAZINE FOR INTENSIVE TREATMENT OF SCHIZOPHRENICS REFRACTORY TO OTHER TRANQUILIZING DRUGS
    HOLLISTER, LE
    TRAUB, L
    PRUSMACK, JJ
    [J]. JOURNAL OF NEUROPSYCHIATRY, 1960, 1 (04): : 200 - 204
  • [33] A PRELIMINARY DOSE-RANGING TRIAL OF PROGLUMIDE FOR THE TREATMENT OF REFRACTORY SCHIZOPHRENICS
    HICKS, PB
    VINOGRADOV, S
    RINEY, SJ
    SU, K
    CSERNANSKY, JG
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1989, 9 (03) : 209 - 212
  • [34] Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations
    Kanamori, Kenta
    Aoyagi, Takashi
    Mikamo, Takashi
    Tsutsui, Kenta
    Kunishima, Tomoyuki
    Inaba, Hideko
    Hayami, Noriyuki
    Murakawa, Yuji
    [J]. INTERNATIONAL HEART JOURNAL, 2015, 56 (05) : 555 - 557
  • [35] Increased lipid peroxidation and neuron specific enolase in treatment refractory schizophrenics
    Medina-Hernandez, V.
    Ramos-Loyo, J.
    Luquin, S.
    Cerdan Sanchez, L. F.
    Garcia-Estrada, J.
    Navarro-Ruiz, A.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2007, 41 (08) : 652 - 658
  • [36] Weight changes associated with treatment with orally disintegrating olanzapine
    Maguire, G.
    Fawver, J.
    Jensen, B.
    Nguyen, C.
    Kumbhani, S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S284 - S284
  • [37] Treatment of corticosteroid-induced mood changes with olanzapine
    Brown, ES
    Khan, DA
    Suppes, T
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06): : 968 - 968
  • [38] Electrical Conductivity Changes During Irreversible Electroporation Treatment of Brain Cancer
    Garcia, Paulo A.
    Rossmeisl, John H., Jr.
    Davalos, Rafael V.
    [J]. 2011 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2011, : 739 - 742
  • [39] Open-label olanzapine monotherapy in treatment refractory bipolar mania
    Colangelo, E. M.
    Muzina, D. J.
    Negrelli, J.
    Conroy, C.
    Calabrese, J. R.
    [J]. BIPOLAR DISORDERS, 2007, 9 : 29 - 29
  • [40] Olanzapine for treatment-refractory psychosis in patients responsive to, but intolerant of, clozapine
    Weiss, EL
    Longhurst, JG
    Bowers, MB
    Mazure, CM
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (04) : 378 - 380